A Belgian man with a serious degenerative blood disease has told the media that he has applied for euthanasia because he cannot afford the expensive medication he needs to live a normal life.
Christophe (no surname was given) has four children, aged 4 to 10, but he separated from his partner two years ago. He is living alone and can no longer work. When his children visit on the weekends, his parents need to accompany them in case he falls or faints.
He suffers from a rare disorder, paroxysmal nocturnal hemoglobinuria, which destroys red blood cells. Patients have a life expectancy of 10 to 20 years from the time of diagnosis. Christophe is constantly fatigued, falls, and suffers from breathlessness and swollen glands.
PNH is rare, with an annual rate of 1 to 2 cases per million and there are only two known treatments: a bone marrow transplant and a drug called Eculizumab (or Soliris) which costs US$500,000 annually. None of Christophe’s relatives are a good match for a transplant and he cannot afford Eculizumab, even with help of Belgium’s healthcare system.
He began thinking about euthanasia three years ago. A year ago, he started doing the paperwork. "I sleep all the time, that's why I'm waiting for euthanasia, I'm waiting for the answer ... because if I can only live like this ... like a vegetable," he told the Belgian outlet RTL.
Michael Cook is editor of BioEdge
This article is published by
and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines
. If you teach at a university we ask that your department make a donation. Commercial media must contact us
for permission and fees. Some articles on this site are published under different terms.